Latin America Allergy Diagnostics Market Size, Share, Growth, Trends and Industry Analysis: By Test Type (Skin Test, Blood Test and Others), By Allergen (Inhaled Allergens, Food Allergens and Others (Drugs)), By End-User (Diagnostic Labs, Academic Research Institutes and Others (Clinics)), and Country Forecast 2020-2031

Latin America Allergy Diagnostics Market size was valued at US$ 2,090 million in 2024 and is expected to reach US$ 3,205 million by 2031, growing at a significant CAGR of 6.3% from 2025-2031. The market is well known that the prevalence of allergic diseases has increased in recent decades in the industrialized world. In effect, air pollution is a growing public health problem. The prevalence of allergic diseases has been increasing rapidly. Exposure to environmental pollutants may partially account for this increased prevalence. The market Rapid urbanization and increased energy consumption worldwide have exposed the human body to not only increased quantities of ambient air pollution, but also a greater variety of pollutants. Various adverse health outcomes such as allergic disease can be attributed to rapidly increasing air pollution levels.

Allergic reactions occur when a person’s immune system reacts to harmless substances called allergens in the environment. Thus, life style, exposure to certain allergens and to environmental contaminants or pollutants both indoors (e.g., tobacco smoke) and outdoors (air pollution), or exposure to microorganisms, may account for the observed increase in prevalence Exposure to traffic-related air pollutants as been implicated in asthma development, persistence, and exacerbation. This exposure is highly significant because increasingly large segments of the population worldwide reside in zones that have high levels of TRAP, including children since schools are often located in high traffic pollution exposure areas.

Hence, rising environmental pollution levels increases allergic diseases and therefore increases demand for the market. The market is surging owing to expansion of their production facilities for allergy diagnostics to meet the demands of the customers in the market. For Instance, On May, 2018, Thermo Fisher Scientific acquired Phadia. The acquisition of Phadia is a major step forward in their strategy to enhance Thermo Fisher's global presence in specialty diagnostics, one of the key growth platforms. Based on country, Brazil accounted for larger market revenue share in 2018 and projected gain market revenue share over the forecast period. Players focusing on innovation of newer products and collaboration strategies to retain market position in global allergy diagnostics market